Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma

Cancer

Volumn 120, Issue 24, 2014, Pages 3987-3993

  Lee, Jean S ^a   DuBois, Steven G ^a   Boscardin, W John ^b   Wustrack, Rosanna L ^b   Goldsby, Robert E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescents; Children; Late effects; Osteosarcoma; Secondary malignant neoplasm (SMN); Young adults

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVOR; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STANDARDIZED INCIDENCE RATIO; SURVIVAL RATE; YOUNG ADULT; BONE NEOPLASMS; CANCER REGISTRY; INCIDENCE; INFANT; NEOPLASMS, SECOND PRIMARY; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; SURVIVOR; UNITED STATES;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; SEER PROGRAM; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84919328908     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28936     Document Type: Article

References (19)

1. Jaffe N. Historical perspective of the treatment of osteosarcoma: an interview with Dr Norman Jaffe. Interview by Margaret Pearson. J Pediatr Oncol Nurs. 1998; 15: 90-94.
2. Friedman MA, Carter SK. The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol. 1972; 4: 482-510.
3. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986; 314: 1600-1606.
4. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatmentwhere do we stand? A state of the art review. Cancer Treat Rev. 2014; 40: 523-532.
5. Aung L, Gorlick RG, Shi W, et al. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience. Cancer. 2002; 95: 1728-1734.
6. Bacci G, Ferrari C, Longhi A, et al. Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Pediatr Hematol Oncol. 2006; 28: 774-780.
7. Longhi A, Ferrari S, Tamburini A, et al. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006). Cancer. 2012; 118: 5050-5059.
8. Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer. 1997; 80: 960-965.
9. Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat Database: Incidence-SEER 18 Regs Research Data- 1Hurricane Katrina Impacted Louisiana Cases, Nov. 2012 Sub (1973-2010 varying)-Linked To County Attributes-Total US, 1969- 2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013
10. Coviello V, Boggess MM. Cumulative incidence estimation in the presence of competing risks. Stata J. 2004; 4: 103-112.
11. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94: 496-509.
12. Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat Database: Incidence-SEER 9 Regs Research Data, Nov. 2012 Sub (1973-2010) - Linked To County Attributes-Total US, 1969-2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013
13. StataCorp. Stata Statistical Software: Release College Station, TX: StataCorp LP; 2013
14. St. Jude Children's Research Hospital. The Childhood Cancer Survivor Study: Baseline Data. stjude.org/ccss. Accessed January 18, 2014.
15. Nagarajan R, Kamruzzaman A, Ness KK, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011; 117: 625-634.
16. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst. 2001; 93: 618-629.
17. Bhatia S, Krailo MD, Chen Z, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group. Blood. 2007; 109: 46-51.
18. Goldsby R, Burke C, Nagarajan R, et al. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Cancer. 2008; 113: 2597-2604.
19. Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet. 2003; 11: 611-618.